Diagnostic Value of PCR and ELISA for Chlamydia trachomatis in a Group of Asymptomatic and Symptomatic Women in Isfahan, Iran

被引:0
作者
Jenab, Anahita [1 ]
Golbang, Naser [1 ]
Golbang, Pouran [2 ]
Chamani-Tabriz, Leili [3 ]
Roghanian, Rasoul [1 ]
机构
[1] Univ Isfahan, Dept Biol, Fac Sci, Esfahan, Iran
[2] Shahid Beheshti Hosp, Esfahan, Iran
[3] Avesina Res Inst, Reprod Infect Dept, Reprod Biotechnol Res Ctr, Tehran, Iran
关键词
Chlamydia trachomatis; Chlamydia trachomatis Infection; Sexually Transmitted Diseases; PCR; ELISA; TUBAL FACTOR SUBFERTILITY; HUMAN-PAPILLOMAVIRUS; INFECTION; PREVALENCE; ANTIBODIES; PREGNANCY; SAMPLES; ASSAYS; DNA;
D O I
暂无
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Background: Chlamydia trachomatis infections are the most prevalent sexually transmitted bacterial infections (STI) in the world that lead to a cause of tubal factor infertility in women. The aim of this study is to determine the presence of C. trachomatis by polymerase chain reaction (PCR) and ELISA. Materials and Methods: Endocervical swabs were collected from 80 women; 22 of them were asymptomatic and 58 symptomatic. Samples were examined by PCR designed to detect Chlamydial plasmid using specific KL1 and KL2 primers. Serum IgG and IgA antibodies to C. trachomatis were detected by ELISA. Since elevated CRP levels are a marker for inflammation, the presence of C- Reactive protein (CRP) has also been evaluated in all samples. Results: The rate of C. trachomatis infection by PCR was revealed to be 27.2% and 18.9% in asymptomatic and symptomatic women, respectively The chi(2) test shows no significant difference (p value=0.22). Serological screening was done on all samples. The high level of IgG and IgA to C. trachomatis infection was 29.4% and 17.6%, respectively. The presence of high levels of CRP, as a serological marker of persistence infection, was 31.8% and 34.4% in asymptomatic and symptomatic women, respectively. The high rate of CRP level in the samples indicates acute infections in both groups. Conclusion: Genital C. trachomatis infection is the leading cause of tubal factor infertility. The present study shows that C. trachomatis infection could be present in symptomatic as well as asymptomatic women. Therefore, a screening test for C. trachomatis infection is recommended for all women who refer to gynecologic outpatient departments in Isfahan and other parts of Iran.
引用
收藏
页码:193 / 198
页数:6
相关论文
共 27 条
[1]   The prevalence of Chlamydia trachomatis in fresh tissue specimens from patients with ectopic pregnancy or tubal factor infertility as determined by PCR and in-situ hybridisation [J].
Barlow, REL ;
Cooke, ID ;
Odukoya, O ;
Heatley, MK ;
Jenkins, J ;
Narayansingh, G ;
Ramsewak, SS ;
Eley, A .
JOURNAL OF MEDICAL MICROBIOLOGY, 2001, 50 (10) :902-908
[2]   Comparison of serological assays for detection of Chlamydia trachomatis antibodies in different groups of obstetrical and gynecological patients [J].
Bax, CJ ;
Mutsaers, JAEM ;
Jansen, CL ;
Trimbos, JB ;
Dörr, PJ ;
Oostvogel, PM .
CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY, 2003, 10 (01) :174-176
[4]   DIAGNOSIS OF CHLAMYDIA-TRACHOMATIS CERVICAL INFECTION BY DETECTION OF AMPLIFIED DNA WITH AN ENZYME-IMMUNOASSAY [J].
BOBO, L ;
COUTLEE, F ;
YOLKEN, RH ;
QUINN, T ;
VISCIDI, RP .
JOURNAL OF CLINICAL MICROBIOLOGY, 1990, 28 (09) :1968-1973
[5]  
Chamani-Tabriz Leili, 2007, Pak J Biol Sci, V10, P4490, DOI 10.3923/pjbs.2007.4490.4494
[6]   Chlamydia trachomatis-associated tubal factor subfertility:: immunogenetic aspects and serological screening [J].
den Hartog, J. E. ;
Morre, S. A. ;
Land, J. A. .
HUMAN REPRODUCTION UPDATE, 2006, 12 (06) :719-730
[7]   Serological markers of persistent C-trachomatis infections in women with tubal factor subfertility [J].
den Hartog, JE ;
Land, JA ;
Stassen, FRM ;
Kessels, AGH ;
Bruggeman, CA .
HUMAN REPRODUCTION, 2005, 20 (04) :986-990
[8]   Prevalence of Chlamydia trachomatis among women attending gynecology and infertility clinics in Gaza, Palestine [J].
El Qouqa, Iyad A. ;
Shubair, Mohammad E. ;
Al Jarousha, Abdel Moati ;
Sharif, Fade A. .
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2009, 13 (03) :334-341
[9]  
Fallah F, 2005, IRAN J PUBLIC HEALTH, V34, P20
[10]  
Filipp E, 2008, GINEKOL POL, V79, P264